(Q36689031)

15 August 2017

1 reference

title

Live vaccines for human metapneumovirus designed by reverse genetics (English)

1 reference

15 August 2017

1 reference

Human metapneumovirus

object named as

human metapneumovirus

1 reference

3

Brian R Murphy

1 reference

15 August 2017

Ursula J Buchholz

1

1 reference

PubMed ID

17181442

15 August 2017

Kunio Nagashima

series ordinal

2

1 reference

PubMed ID

17181442

15 August 2017

Peter L Collins

series ordinal

4

1 reference

15 August 2017

1 October 2006

1 reference

Expert Review of Vaccines

15 August 2017

1 reference

15 August 2017

5

1 reference

15 August 2017

695-706

1 reference

15 August 2017

5

1 reference

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Human metapneumovirus as a major cause of human respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Human Metapneumovirus Infection in the Canadian Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Human metapneumovirus infection in Japanese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Use of the P gene to genotype human metapneumovirus identifies 4 viral subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Human metapneumovirus: a new player among respiratory viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Characterization of human metapneumoviruses isolated from patients in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Human metapneumovirus as a cause of community-acquired respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Genetic diversity between human metapneumovirus subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Analysis of the genomic sequence of a human metapneumovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in vero cells and does not alter tissue tropism in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Sequence polymorphism of the predicted human metapneumovirus G glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Genetic variability of the G glycoprotein gene of human metapneumovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

High genetic diversity of the attachment (G) protein of human metapneumovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Seasonal distribution and phylogenetic analysis of human metapneumovirus among children in Osaka City, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Limited inter- and intra-patient sequence diversity of the genetic lineage A human metapneumovirus fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Antigenic and genetic variability of human metapneumoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Clinical impact and diagnosis of human metapneumovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Human metapneumovirus infections in young and elderly adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Viral pneumonia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Immune responses to measles and measles vaccine: challenges for measles control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Current status of live attenuated influenza virus vaccine in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Vaccines for the prevention of respiratory viral infections: problems and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Influence of maternal antibodies on neonatal immunization against respiratory viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Respiratory syncytial virus: reverse genetics and vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Modeling the structure of the respiratory syncytial virus small hydrophobic protein by silent-mutation analysis of global searching molecular dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Support plasmids and support proteins required for recovery of recombinant respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Codon substitution mutations at two positions in the L polymerase protein of human parainfluenza virus type 1 yield viruses with a spectrum of attenuation in vivo and increased phenotypic stability in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Live-attenuated intranasal parainfluenza virus type 2 vaccine candidates developed by reverse genetics containing L polymerase protein mutations imported from heterologous paramyxoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Production and characterization of neutralizing monoclonal antibodies against human metapneumovirus F protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.695

21 January 2018

Identifiers

DOI

10.1586/14760584.5.5.695

1 reference

15 August 2017

1 reference

PubMed ID

17181442